Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis

Am J Ophthalmol. 2002 Nov;134(5):780-2. doi: 10.1016/s0002-9394(02)01629-x.

Abstract

Purpose: To describe a combined pharmacological and surgical approach to treating acquired nystagmus in a patient with multiple sclerosis.

Design: Interventional case report.

Methods: A 40-year-old patient with acquired horizontal and vertical nystagmus and severe oscillopsia secondary to multiple sclerosis had combined treatment with gabapentin and a vertical Kestenbaum-type procedure.

Results: After gabapentin treatment (3,000 mg orally daily) the horizontal nystagmus was significantly reduced, and the patient developed a marked chin-up position. The vertical nystagmus remained unchanged, dampening on downgaze. A recession of both inferior rectus muscles reduced the nystagmus significantly in primary position, the abnormal head position disappeared, and oscillopsia completely resolved. Treatment increased visual acuity from 6/24 in the right eye and 6/60 in the left eye to 6/9 in both eyes.

Conclusions: Acquired nystagmus in multiple sclerosis can be significantly improved by using a combined pharmacological and surgical approach.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / therapeutic use*
  • Adult
  • Amines*
  • Combined Modality Therapy
  • Cyclohexanecarboxylic Acids*
  • Diplopia / etiology
  • Diplopia / therapy*
  • Excitatory Amino Acid Antagonists / therapeutic use*
  • Gabapentin
  • Head Movements
  • Humans
  • Male
  • Multiple Sclerosis / complications*
  • Nystagmus, Pathologic / etiology
  • Nystagmus, Pathologic / therapy*
  • Oculomotor Muscles / surgery
  • Ophthalmologic Surgical Procedures*
  • Posture
  • Visual Acuity
  • gamma-Aminobutyric Acid*

Substances

  • Acetates
  • Amines
  • Cyclohexanecarboxylic Acids
  • Excitatory Amino Acid Antagonists
  • gamma-Aminobutyric Acid
  • Gabapentin